Financial News
Press Releases about Royalty Pharma Plc Cl A
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
Royalty Pharma Reports First Quarter 2023 Results
May 09, 2023
From Royalty Pharma plc
Via GlobeNewswire
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
Royalty Pharma Declares Second Quarter 2023 Dividend
April 17, 2023
From Royalty Pharma plc
Via GlobeNewswire
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
From Royalty Pharma plc
Via GlobeNewswire
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
![](https://mms.businesswire.com/media/20230323005234/en/1396139/5/2022_Horizontal_transparent_white.jpg)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
Royalty Pharma Raises Full Year 2023 Guidance
March 15, 2023
From Royalty Pharma plc
Via GlobeNewswire
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
Royalty Pharma Reports Q4 and Full Year 2022 Results
February 15, 2023
From Royalty Pharma plc
Via GlobeNewswire
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
Royalty Pharma to Present at Upcoming Investor Conferences
February 09, 2023
From Royalty Pharma plc
Via GlobeNewswire
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
Royalty Pharma Announces Dividend Increase
January 09, 2023
From Royalty Pharma plc
Via GlobeNewswire
![](https://www.globenewswire.com/Content/Images/intrado.png)
From Royalty Pharma plc
Via GlobeNewswire
![](https://www.globenewswire.com/Content/Images/intrado.png)
Royalty Pharma Announces Expansion of Senior Leadership Team
December 15, 2022
From Royalty Pharma plc
Via GlobeNewswire
![](https://www.globenewswire.com/Content/Images/intrado.png)
Royalty Pharma to Present at Evercore ISI 5th Annual HealthCONx Virtual Conference
November 28, 2022
From Royalty Pharma plc
Via GlobeNewswire
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://mms.businesswire.com/media/20221109005596/en/523535/5/ah_logo_cmyk.jpg)
![](https://www.globenewswire.com/Content/Images/intrado.png)
Royalty Pharma Reports Third Quarter 2022 Results
November 08, 2022
From Royalty Pharma plc
Via GlobeNewswire
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
Royalty Pharma Declares Fourth Quarter 2022 Dividend
October 17, 2022
From Royalty Pharma plc
Via GlobeNewswire
![](https://www.globenewswire.com/Content/Images/intrado.png)
Royalty Pharma Announces Expansion of Leadership Team
October 12, 2022
From Royalty Pharma plc
Via GlobeNewswire
![](https://www.globenewswire.com/Content/Images/intrado.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.